3Frerman FE,Goodman SI.Deficiency of electron transfer flavoprotein or electron transfer fiavoprotein:ubiquinone oxidoreductase in glutaric acidemia type Ⅱ fibroblasts.Proc Natl Acad Sci U S A,1985,82 (13):4517-4520.
4Henriques BJ,Rodrigues JV,Olsen RK,et al.Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency:a molecular rationale for the effects of riboflavin supplementation.J Biol Chem,2009,284(7):4222-4229.
5Tamaoki Y,Kimura M,Hasegawa Y,et al.A survey of Japanese patients with mitochondrial fatty acid beta-oxidation and related disorders as detected from 1985 to 2000.Brain Dev,2002,24 (7):675-680.
6Ohkuma A,Noguchi S,Sugie H,et al.Clinical and genetic analysis of lipid storage myopathies.Muscle Nerve,2009,39(3):333-342.
7Han LS,Ye J,Qiu WJ,et al.Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China:a four-year report.J Inherit Metab Dis,2007,30(4):507-514.
8Frerman FE,Goodman ST.The metabolic and molecular bases of inherited diseases.8th.New York:McGraw-Hill,2001:2357-2365.
9Olsen RK,Olpin SE,Andresen BS,et al.ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.Brain,2007,130(8):2045-2054.
10Gempel K,Topaloglu H,Talim B,et al.The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron transferring flavoprotein dehydrogenase (ETFDH) gene.Brain,2007,130 (8):2037-2044.
